Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001144204-15-026590
Filing Date
2015-04-30
Accepted
2015-04-30 16:35:28
Documents
6
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A v408985_10ka.htm 10-K/A 248640
2 EXHIBIT 31.1 v408985_ex31-1.htm EX-31.1 3576
3 EXHIBIT 31.2 v408985_ex31-2.htm EX-31.2 3405
4 EXHIBIT 32.1 v408985_ex32-1.htm EX-32.1 4335
5 EXHIBIT 32.2 v408985_ex32-2.htm EX-32.2 4043
6 GRAPHIC tlogo.jpg GRAPHIC 12911
  Complete submission text file 0001144204-15-026590.txt   283040
Mailing Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019
Business Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019 781-652-4500
Fortress Biotech, Inc. (Filer) CIK: 0001429260 (see all company filings)

EIN.: 205157386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-35366 | Film No.: 15819318
SIC: 2834 Pharmaceutical Preparations